InChI=1S/C25H45NO9/c1- 14- 12- 25(33- 9,35- 16(3) 15(14) 2) 21(28) 22(29) 26- 23(32- 8) 18- 11- 19(27) 24(4,5) 20(34- 18) 10- 17(31- 7) 13- 30- 6/h15- 21,23,27- 28H,1,10- 13H2,2- 9H3,(H,26,29) /t15- ,16- ,17+,18+,19- ,20- ,21- ,23+,25- /m1/s1 |
ZNEZZONMADKYTB-VRCUBXEUSA-N |
COC[C@H] (C[C@H] 1O[C@@H] (C[C@@H] (O) C1(C) C) [C@@H] (NC(=O) [C@@H] (O) [C@] 1(CC(=C) [C@@H] (C) [C@@H] (C) O1) OC) OC) OC |
|
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
vesicant
Any compound that causes severe skin, eye and mucosal pain and irritation.
antimitotic
Any compound that inhibits cell division (mitosis).
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(2S)- N- [(S)- {(2S,4R,6R)- 6- [(2S)- 2,3- dimethoxypropyl]- 4- hydroxy- 5,5- dimethyltetrahydro- 2H- pyran- 2- yl}(methoxy)methyl]- 2- hydroxy- 2- [(2R,5R,6R)- 2- methoxy- 5,6- dimethyl- 4- methylenetetrahydro- 2H- pyran- 2- yl]acetamide
|
(+)-pederin
|
ChEBI
|
(+)-pederine
|
ChEBI
|
paederine
|
ChEBI
|
pederine
|
ChemIDplus
|
27973-72-4
|
CAS Registry Number
|
KEGG COMPOUND
|
27973-72-4
|
CAS Registry Number
|
ChemIDplus
|
3598743
|
Reaxys Registry Number
|
Reaxys
|
11077605
|
PubMed citation
|
Europe PMC
|
11166312
|
PubMed citation
|
Europe PMC
|
11886773
|
PubMed citation
|
Europe PMC
|
12057588
|
PubMed citation
|
Europe PMC
|
12381784
|
PubMed citation
|
Europe PMC
|
14695518
|
PubMed citation
|
Europe PMC
|
17645272
|
PubMed citation
|
Europe PMC
|
19206228
|
PubMed citation
|
Europe PMC
|
21268211
|
PubMed citation
|
Europe PMC
|
21426381
|
PubMed citation
|
Europe PMC
|
21902245
|
PubMed citation
|
Europe PMC
|
22444588
|
PubMed citation
|
Europe PMC
|
22772477
|
PubMed citation
|
Europe PMC
|
23581998
|
PubMed citation
|
Europe PMC
|
23898213
|
PubMed citation
|
Europe PMC
|
3295241
|
PubMed citation
|
Europe PMC
|
5959934
|
PubMed citation
|
Europe PMC
|
|